Axon Enterprise (NASDAQ:AXON) Insider Isaiah Fields Sells 1,017 Shares of Stock

Axon Enterprise, Inc (NASDAQ:AXON) insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider owned 56,264 shares in the company, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise Trading Up 2.3%

NASDAQ AXON traded up $10.84 during trading on Monday, reaching $490.18. 577,509 shares of the stock traded hands, compared to its average volume of 1,039,278. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $792.16. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The firm has a market cap of $39.82 billion, a price-to-earnings ratio of 203.40, a price-to-earnings-growth ratio of 9.02 and a beta of 1.40. The stock’s 50-day moving average price is $561.67 and its 200 day moving average price is $488.81.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same period last year, the firm posted $2.12 earnings per share. The business’s quarterly revenue was up 35.3% compared to the same quarter last year. Analysts predict that Axon Enterprise, Inc will post 2.12 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $28,000. Keating Financial Advisory Services Inc. acquired a new position in shares of Axon Enterprise in the second quarter valued at about $31,000. Washington Trust Advisors Inc. grew its position in shares of Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares in the last quarter. Delos Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $45,000. Finally, Owl Creek Wealth Partners LLC increased its holdings in shares of Axon Enterprise by 84.8% during the second quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 39 shares during the period. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AXON. UBS Group increased their target price on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Citizens Jmp reissued a “market outperform” rating and set a $700.00 price objective on shares of Axon Enterprise in a research report on Thursday, June 25th. Morgan Stanley upped their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $715.00 target price on shares of Axon Enterprise in a report on Thursday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $721.57.

About Axon Enterprise

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.

The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.